IP Library › Granted Patent US 12,667,599
Granted Patent B2
US 12,667,599 · App. 18/090,898 · Granted Jun 30, 2026

Pharmaceutical composition or health functional food for prevention and treatment of obesity containing powder of novel hybrid mushroom as active ingredient

Inventors: Tae Hoon Lee (Seoul, KR); Jae Wang Ghim (Gyeongsangbuk-do, KR)
Assignees: Novacell Technology Inc.; Gyongsangbuk-do
A61K36/07A23L33/10A23L33/30A61P1/16A61P3/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,667,599
App. No.
18/090,898
Granted
Jun 30, 2026
Kind
B2
Abstract

The present invention provides a pharmaceutical composition for the treatment of obesity and fatty liver disease caused due to a high-fat diet, containing, as an active ingredient, the powder of a fruiting body or a mycelium of hybrid mushroom strain GBN2WP0970 having no side effects and an excellent triglyceride absorption inhibitory effect.

Claims (6)

1 . A method for treating fatty liver disease in a subject, comprising administering a therapeutically effective amount of powder of a fruiting body or a mycelium of hybrid mushroom Pleurotus sp. GBN2WP0970 to the subject.

2 . The method of claim 1 , wherein the hybrid mushroom Pleurotus sp. GBN2WP0970 is generated by crossbreeding of Pleurotus eryngii var. ferulea (Pf.) and Pleurotus ostreatus.

3 . The method of claim 1 , wherein the fatty liver disease is non-alcoholic fatty liver disease.

4 . The method of claim 3 , wherein the non-alcoholic fatty liver disease is non-alcoholic fatty liver, non-alcoholic steatohepatitis, or non-alcoholic fatty liver-related cirrhosis.

5 . A method for treating obesity in a subject, comprising administering a therapeutically effective amount of powder of a fruiting body or a mycelium of hybrid mushroom Pleurotus sp. GBN2WP0970 to the subject.

6 . The method of claim 5 , wherein the hybrid mushroom Pleurotus sp. GBN2WP0970 is generated by crossbreeding of Pleurotus eryngii var. ferulea (Pf.) and Pleurotus ostreatus.